Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$854,651
New position
Shares Held
24,170
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Seven Fleet Capital Management LP holds $10,142,245 across 6 Drug Manufacturers - Specialty & Generic names. ALKS ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
187,876 | $7,090,440 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
102,493 | $975,733 | |
| 3 | ALKS |
Alkermes plc.
This page
|
24,170 | $854,651 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,128 | $668,881 | |
| 5 | EOLS |
Evolus, Inc.
|
78,057 | $320,814 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
16,671 | $231,726 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $854,651 | 24,170 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||